ERBB2 and breast cancer: Breast cancer prognosis estimated by stroma-derived prognostic predictor, which was developed from gene profiling of 53 primary breast tumor stroma, was independent of estrogen receptor expression, HER2 expression, grade, lymph nodal involvement, age, previous chemotherapy or hormonal therapy status [47].